FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

23663711000001105: Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jan 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
77297301000001116 Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
77297401000001112 Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram Has VMP Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oral gel sugar free true Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram Has specific active ingredient Cetylpyridinium chloride true Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram Has dispensed dose form Conventional release oromucosal gel true Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bonjela Junior gel (Reckitt Benckiser Healthcare (UK) Ltd) 15 gram Is a True Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start